Charles Schwab’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Buy |
95,774
+80,774
| +538% | +$245K | ﹤0.01% | 3320 |
|
|
2025
Q1 | $63.9K | Buy |
+15,000
| New | +$63.9K | ﹤0.01% | 3386 |
|
|
2021
Q2 | – | Sell |
-12,060
| Closed | -$190K | – | 3534 |
|
|
2021
Q1 | $190K | Hold |
12,060
| – | – | ﹤0.01% | 3324 |
|
|
2020
Q4 | $292K | Buy |
+12,060
| New | +$292K | ﹤0.01% | 3168 |
|
|
2016
Q2 | – | Sell |
-275
| Closed | -$86K | – | 3132 |
|
|
2016
Q1 | $86K | Hold |
275
| – | – | ﹤0.01% | 2999 |
|
|
2015
Q4 | $171K | Hold |
275
| – | – | ﹤0.01% | 2990 |
|
|
2015
Q3 | $153K | Hold |
275
| – | – | ﹤0.01% | 2995 |
|
|
2015
Q2 | $197K | Buy |
+275
| New | +$197K | ﹤0.01% | 2981 |
|